FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

789691007: Antileprotic therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2020. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3791977012 Antileprotic therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module
3791978019 Antileprotic therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antileprotic therapeutic role Is a Antimycobacterial therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Medicinal product acting as antileprotic agent (product) Plays role True Antileprotic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely dapsone 50 milligram/1 each conventional release oral tablet Plays role True Antileprotic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely dapsone 100 milligram/1 each conventional release oral tablet Plays role True Antileprotic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clofazimine 100 milligram/1 each conventional release oral capsule Plays role True Antileprotic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet Plays role True Antileprotic therapeutic role Inferred relationship Existential restriction modifier
Product containing dapsone in oral dose form (medicinal product form) Plays role True Antileprotic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely dapsone 25 milligram/1 each conventional release oral tablet Plays role True Antileprotic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clofazimine 50 milligram/1 each conventional release oral capsule Plays role True Antileprotic therapeutic role Inferred relationship Existential restriction modifier
Product containing clofazimine Plays role True Antileprotic therapeutic role Inferred relationship Existential restriction modifier
Product containing clofazimine in oral dose form (medicinal product form) Plays role True Antileprotic therapeutic role Inferred relationship Existential restriction modifier
Product containing only clofazimine in oral dose form (medicinal product form) Plays role True Antileprotic therapeutic role Inferred relationship Existential restriction modifier
Product containing only dapsone and pyrimethamine in oral dose form (medicinal product form) Plays role True Antileprotic therapeutic role Inferred relationship Existential restriction modifier
Product containing only dapsone in oral dose form (medicinal product form) Plays role True Antileprotic therapeutic role Inferred relationship Existential restriction modifier
Clofazimine Plays role True Antileprotic therapeutic role Inferred relationship Existential restriction modifier
Product containing dapsone and pyrimethamine in oral dose form (medicinal product form) Plays role True Antileprotic therapeutic role Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start